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D91757 Prognostic Value of Dobutamine Echocardiographyin Patients With Coronary Artery Disease And
Severe Left Ventricular Dysfunction
U. Klaar,H.Baumgartner,M. Wutte,S. Khan,M. DeRobertis,Y. Kong-Lsu,
R. Siegel,G. Laufar, G. Maurer. Dews. of Cardiology arrd Sugey, Univ of
Vienna,Austria, Cedars-Sinai Medical Cente6 Los Angeles. CA, USA
The prognosticvalue of dobutamineecho on sunfivalin pts with coronary
arterydiseaseandsevere leftventriculardysfunctionisstillunknown.There-
fore, we studiedthe outcome (mean F/U 2.9 + 1.3 yrs) of 61 pts (M/F
50/11, age 80.5 + 10.1 yrs, EF 23.3 + 10.3%) who underwantdobutamina
echo. A 16-segmentmodel was used for semiquantitativeassessmentof
wallmotionat restandafteradministrationof5, 10,20, 30, and40 wg/kg/min
dobutamine.Segmentswere definedas viablewhenpresentingwithnormal
wall motionat restor when rest asynergyimprovedby at least one grade
with dobutamkre.CMthe 61 pts, 28 ultimatelyunderwentbypasssurgery.
6 of these died duringF/U whereas 22 were still alive. 13 pts underwent
hearttransplantation(HTX). Of the 20 pts withoutsurgicaltreatment13 pts
were stillalive whereas 7 pts died. CABG survivorshad significantlymore
viablesegmentsbydobutamineecho.Therewasonlya trendtowardshigher
EF but no statisticallysignificantdifferenceoomparedto ptswho died after
CABG. In contrast,in the non-CABGgroup,EF predictedsurvival,whereas
nosignificantdifferencewas foundby dobutamineecho.
CABG NoCABG
Alive Dead Alive DeadorHTX
N 22 6 13 20
# ViableSeg, 12.6&2.7 9.7+2.8’ 9.5k 2.8 9,4+ 3.9
LV-EF(OA) 30.0+ t2.3 24.Sk6.5 24.0+ 9.6 16.9+5.Ot
(’PS 0.05comParedtoalive/CABG,‘p= 0.05comparedtoalive/noCABG).
Thus,dobutamineechoidentificationofviablesegmentsappearstoserve
asa strongindependentpredictoroflong-termsurvivalinpatientsundergoing
CABG and may offer prognostic information above and beyond ejection
fraction.
D91770 Dobutamine-AtroPine Strese Echocardiography iaAccurate for Predicting the Extent of Coronary
Artery Disease
S. Smart,P.Dionisopoulos,K. Sagar. The Medical College of Wisconein,
Milwaukee, WI. USA
Dobutamina-atropinastress echocardiography(DSE) has been shownto
accuratelydetect the presence of coronaryartery diseaee (CAD), but its
accuracy for predictingthe extent of disease ie unknown.To determine
accuracyfor extent of CAD, 288 patiente(age 61 + 11 yearn, 187 men)
underwentDSE and coronaryangiographywithin2 montheof each other.
Atropinewas used in 145 patients. Peak haarl rate was 128 i.l7-bprn:-
DSE waa normal in 98 patients.Wall motionabnormalities(WMA) ware
detectedin 1 vascularterritory(1 VT) in 98 patients,2 VT in 58, and all 3
VT in 34. Angiographyrevealedno CAD (<50% Iuminaldiameteretenosis)
in 79 patients,singlevessel (IV) CAD in 67, 2V CAD in 77, and 3V CAD in
45. The saneitivityand specificityof multipleWMA for 2V or 3V CAD were
70% (185/122) and 98% (159/186), reepactively.Correlationof DSE and
angiographywas:
bVMAbyDSE
CADbyAnglo: 3vr 2VT lVT o Total
3V 16 16 7 4 45
2V 15 36 19 7 77
lV 3 4 63 17 S7
o 0 0 9 70 79
Total 34 56 96 98 288
ThenumbarofWMAcorrelatedwell(Pearson’sR= O.710,p < O.00000001)
withtha extentof angiographicCAD. MultipleWMA are sensitiveand very
specificfor multivesselCAD. In conclusion,the numberof WMA by DSE
accuratelypredictedthe extentof CAD by angiography.
D91771 Predictive Vaiue of Dobutamine StressEchocardiography Performed During g3-Blockada
T. Xie, M. Kumar,M. Khan,M. Adams,J. Esquivel-Avila,M. Ahmad.
University of TexasMedical Branch, Galveston, TX, USA
Three hundredand sixiy patients(pts) either on &Blocker therapy or on
no cardiacmedication duringDobutaminestressechocardiography(DSE)
wereaeleotedoutof 1322 consecutiveDSE studiesperformedfromJanuary
1992throughDecember1995 andwerefollowedforoardiaceventsincluding
unstableangina,myocardialinfarction,congestiveheartfailure,arrhythmia,
revascularlzation,and cardiacdeath, Eighty-ninepts(mean age+ SD, 55 +
10 yrs)on B-Blockers(Group1)were followedfor 18 + 10 monthsand 271
pts (53 + 12 yrs) withoutcardiacmedicationsduringDSE (Group 11)were
followedfor 17 + 9 months.Peak DSE heart rate, baseline/peakDSE LV
ejectionfraction(Mean + SD) were 111.6+ 25,2, 51.6 + 8.6/63.7 + 9.9 in
Group I compared to 131.2 + 19.2, 56.2 + 7.1/70.3 + 8.2 in Group II (p <
0.0001). The useofatropinewas notsignificantlydifferentinthe twogroups.
The sensitivitylevelsfor DSE in detectingischemiain GroupsI and II were
81% and 69%, respectively.Fifteenof 89 patients(16.9%) in Group I had
cardiaceventscomparedto 27 of271 pts(9.9%) inGroupIl. Positivepredic-
tive valuesof DSE were 21% in GroupI and 37% in GroupIl. Slx of 47 pts
withnegativaDSE in GroupI hadcardiaceventscomparedto 12 of 230 pts
in GroupII resultingin negativepredictivevaluesof 87°Aand 95%, respec-
tively(p < 0.05). The data indicatethat inp-Blockedpts, DSE is sensitivein
detectingIschemlahowever,Its negativepredictivevalue for futurecardiac
eventsisdecreasedwhencomparedto ptswithoutcardiacmedications.
/917-72/ E~oximonaE~ho~ardiograPhYfor,den*ifi~ationof
Viable Myocardium in Patients With Iachaemic
Ventricular Dysfunction: Comparison With
Dobutemine Echocardiography and Poeitron
Emission Tomography
M. Carlino,S. Chierchia,C. Lu,A. Margonato,R. Poletd,C. Landoni,
G. Lucignani./RCCS H.San. Raffae/e, Milan, /tafy
Enoximone,a nongiycoeide,noncstecholpositiveinotropicagent has been
proposedin combinationwithtwo-dimensionalechocardiographyas a new
toolto identifymyocardialviability.We studied10 patientswithpreviouamy-
ocerdialinfarction(infarctage, >3 months)and depresaedleft ventricular
function(EF s 40%) by lowdose (5 to 10 &g/kgper rein)dobutamineecho-
cardiography(DE) and enoximone(1 mg/kgintravenously,over 5 minutes)
echocardiography(EE) ontwoconsecutivedays.Myocardialuptakeof F-18
fluorodeoxyglucose(FDG) was assessedby positronemissiontomography
(PET) afterprolonged(> 12 hra)fastingwithin5 daysofthe eohostudy.The
myocardiumwasdefinedasviablewhenthe FDG uptakewas abovethe95%
confidenceintervalassessedinfive normaisubjects.Digitizedecho images
at restand at peakof DE and EE were comparedqualitativelyon a cine-ioop
display,Syatolicfunctionwaa scoredfrom 1 (normal)to 4 (dyskinesia),and
functionalimprovementwas definedas a scorechange >1 grade. Of 126
dysfunctionaleegmente,51 (40%) were viable by PET criteria.Contractile
functionimprovedduringDE and EE, respectively,in 39 and 36 of theee
segmanta.(Sensitivity:DE = 76% ve EE = 71%, p = ns). Conversely,of
75 segmentswithoutPET viability,respectively,69 and 70 did not respond
(specificity:DE= 92% .s EE = 93%, p = ne)to the DE and EE. CoocorCfant
interpretationofEE andDEwasfoundin91% (115/126)ofaffectedsagments
(43 via6Te-and72 nonviable).EE didnotcauseany sideeffectand significant
changeeof heartrate (HR) and eystolicbloodpressure(BPs). In contrastto
EE, DE causedchestpain(n= 2), ischemia(n =2) and ventriculararrhyth-
mia (n= 4) and increaeedHR (by20%) and BP (by 15%). Conclusion: EE ie
an effectivenewteetthatdetecteresidualviabilitywitheeneitivitycomparable
to DE and significantlesssideeffects.
917-73 Extent of Jeopardized Myocardium Correlates With
Heart Rate: A Dobutamine Stress
Echocardiographic Study
K. Ramani,J.A. Lsraen,J.V.Talano,F.A.Chaudhry.Nortfrwestem
University Chicago, IL, USA, Allegheny University of the Heafth Sciences,
Philadelphia, PA, USA
Correlationbetweenextent and severityof coronaryartery disease (CAD)
with heart rate (HR) and/or doubleproductwith dobutaminestress echo-
cardiogrsphy(DSE) is not well defined.Therefore, we evaluated 117 pta
(85 male, 32 female, age 84.5 + 1.1 yrs), who developednew reversible
segmentalwall motionabnormalities(WMA) duringDSE. All pta underwent
cardiaccatheterization(within6 monthsof DSE). Dobutaminewas infusedin
stepwiseincrementsat 10-50 @f@min. Studyendpointwas DSE detection
of WMA, at whichtimeths peak HR and doubleproductwere noted.All pta
CAD Age(yrs) No. M:F Debut PeakHR % PredHR DoubleProduct
NOD 63,5+2.1 19 11:6 27.1+3,2 134.2+2.6 84.2*2.4 21324*1O.4
lVD 64.1+2.2 30 20:10 29.6+2,5 126,S+2.6 84.2+2.4 20443+983
2VD 64.2*2.5 33 28:5 27.6+2.2 120.5+3.9 78.3k2.5 17420+666”
3VD 65.7+1.5 35 26:9 21.0+2.1a 109.9+3.9*b 71.4+2.5 15562+762*.b
‘p <0.001 vs.non-obstructivedisease;bp<0.001 vs.l-vesseldisease;ap<0,05 vs.
all3groups.(Debut=peakdobutaminedosainwglkg.?min)
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had230% Iumlnal stenosis on coronaiy angiography.The extent of CAD waa
classified as one, two or three vessel disease (VD) by the number of major
epicardial vessels with 2707. stenosis. Non-obatruetivedisease (NOD) was
defined as 30-69%. Peak HR was significantly higher in females (p <0.05
vs males) for similar degree of CAD (table).
These data suggest that in multivessel coronary disease, WMAoccursata
Iowerdobutamine dose, HR and double product during DSE. This mrrelates
with greater myocanfiurni jeopardyandmayfurther help in risk stratification
of pte with CAD.
D91774 Immediate Versus DelSyod Myocardial ContrastEchocsrdiogrsphy in Acute Myodardisl Infarction.
Rslation Wtih Contractile Reeerve at Dobutsmine
Echocardiography
E. Brochet, D. Czitrom, D. Karila-Cohen, P.Aubry, P.G.Steg, P.Assayag.
Opt of Cardiology, Hopita/ 6ichat, fans, France
Microvascular integrity (MVI) has been shown to be a prerequisite for my-
ocardial viability and functional recovery after acute myocardial infarction
(Ml). In thie study, early and Iata evaluation of MVI with myocardiai contrast
echocardiography (MCE) were compared to contractile response with low
dose dobutamine echocerdiography (LDDE). In 16 patients with AMI <6
hours, TIMI 3 patency waa obtained with PTCA (n = 13) orthrombolysis (n =
3). MCE was performed during selective coronary angiography immediately
after recanalization, and repeatad 9 + 1 days later. No patient had residusl
flow limiting stenosis. In all hypo or akinetic segments, MCE perfusion was
graded using a semi-quantitative ccntrast score (O,0.5, 1). LDDE was per-
formed 10+ 1 days after AMI (5-15 wg/kg/min). Wall motion score (WMS)
waa graded in each eegment as 1 (norrnokinesia)to 3 (akinesia). Contractile
reserve (CR) was defined as improvement of one or more grade from base-
line study. The average improvement of WMS under dobutamine (ALDD)
wae calculated in each score group of both early and late MCE. Re.suks.’
MCEscore EwIYMCE(dayO) LateMCE(day9)
n CR ALDD n CR ALDD
o 25 8 (32%) 0.60+ 0.9 14 1 (7%) 0.07 + 0.26
05 25 10 (40”A) 0.65+ 0.9 15 4 (27%) 0.40& 0.70. .
1 43 22 i51%j 0.65 + 0.8 64 35 (55%)* 0.76 + 0,85t
“ p< 0.01; t p<0.005(score 1 vsscore O)
Of 25 eegmenta with no-reflow at day O,44% had improved perfusion at
day 9: LDDE documented CR in 64% of them. Contractile responseto LDDE
was reiated to MCE score at day 9 but not at day 0.
Corrc/@on: Although both early and late MCE are useful for the atudy
of MVI, only late assessment of MVI is a reliable indicator of preserved
contractile resewe as assessed by LDDE.
D91775 Diagnostic Accuracy of Dobutsmine StressEchocardiography in Patients with Left Bundle
Branch Block. A Multicenter Study
M.L. Geleijnee, C. Vigna, R. Rambaldi, J.D. Kasprzak, P.M.Fioretti.
Thorexcentec Rotferdam, The Netherlands
Aim of the study: To assess the diagnostic accuracy of dobutarnine-atropine
streas echocardiography (DASE) in patients with permanent, complete left
bundle branch block (LBBB).
Methods: Fifty-nine patients (mean age 60 years, 22 men) with chest
pain and LBB6 but without clinically recognized prior myocardial infarction
underwent DASE. DASE was scored according toa 16(extent) x 5(aeverity)
points model by two blinded obaervera and was considered positive in case
of new or worsening wall motion abnormalities at any stage. Septal move-
ment was assessed by M-mode and classified as: A) normal, B) mildly or C)
saverely impaired posterior movement. Significant coronary artery disease
was defined as 250’%0diameter stenosis at quantitative coronary angiogra-
phy.
Results: Septalmovement was normal in 23, mildly impaired in 16 and
severely impaired in 20 patients. Sixteen patients (27%) had coronary dis-
ease. Interobserver agreement for the detection of ischemia was 51/59
(66%), in all patients the disagreement was in the septum. Disagreement
was present in 5/39 (13%) patients with normal or mildly impaired and in 4/20
(20%) patienta with severely impaired septal movement. Overall sensitivity
and specificity was 11/16 (69%) and 40/43 (93%). Sensitivitiesandspecifici-
tiesfortheanterior(LAD) andposterior (RCA, LCX)circulations were 6/13
(62%) va. 6411(73%) and 43/46 (93%) vs, 46/48 (100%). All but one false
negative test in the anterior circulation occurred in patients with severely
impaired resting septal movement. False negative tests in the posterior cir-
culation occurred in two patients with single vessel LCX disease and one
patient with RCA and LCXdisease.
Conclusions: In generai, DASE seems useful to identify coronay disease
in patients with LBBB. Assessment of ischemia in the anterior circulation in
patients with severely impaired septums, however, suffers from high interob-
.serverdisagreement and lacks good sensitivity.
1917’-7’6I Safety of DObutarnine-AtrophteStress
Echocardiography in Patients With Ventricular
Techycardia
S.Smart, J. Roth, K. Sagar, The Medical College of Wisconsin, Milwaukee,
W/, USA
Dobutamine-atropine stress echocardiography (DSE) is being increasingly
used for the detection of viability and risk stratification in patiente with is-
chemic -and nonischemic cardiomyopathies, but it is unknown whether the
test is safe in patientswith ventricuiartachycardia (VT). Toevaluate the safety
of DSE in these patients, 39 (17 women, age 60 + 14 yre) with symptomatic
nonsustained VT (11 beats to 30 seconds, N = 15), sustained monomorphic
VT (> 30 seconds, N = 20), or ventricular fibrillation (VF) arrest underwent
multi-stage DSE by a modified protocol (rest, 5, 10, up to 25 mg/kg/min and
2.0 mg of atropine in 5-10 min. stages) for evaluation of myocardial viability
(N =35) ortheexfent of coronary arte~disease (CAD, N =4). All patienta had
moderate to severe left ventricular (LV) dysfunction with wall motion score
indices of 2.16+ 0.34. The peak dose of dobutamine was 19+6 mgikglmin.
Atropine was used in 26 patients (72%). Peak haart rate (HR) and blood
pressure were 116 + 15 bpm and 135 + 15 mmHg, respectively. Endpoints
were HR >120 bpm in 20 patients, chest pain in 6, supraventricular tachy-
cardia (SVT) in 3, nonsustained ventricular tachycardia (NSVT 6-7 bpm) in
4, nausea in 3, and 22 mm of ST depression in 3. There were no severe
complications: death, myocardial infarction, or sustained VT. Frequent PVC’s
(> 6 rein) occurred in 8 patients, but all achieved maximal HR. In conclusion,
this pilot study revealed that DSE by this modified protocol of early atropine
infusion can be safely performed in patients with VTiVF and LV dysfunction.
Ventricular arrhythmias do net limit the diagnostic value of the test.
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\918-971AngiOtenSinconVenin9~nZYMe,nhibitOr
Attenuates a-Adrenoceptor Sensitivity in Human
Vessel
M. Kimura, K, Ohasahi, K. Umemura, K. Kosuge, M. Nishimoto,
M. Nakashima. Hamamatsu University Schoo/ofMedicine at Hamamatau,
Japan
Angiotensin II augments the presynaptic and postsynaptic sympathetic ner-
vous activity. An angiotensin converting enzyme inhibitor (ACEI) has bean
reported to reduce sympathetic out flow, however, the influence to postay-
naptic adrenoceptor sensitivity is not detected in human. We investigated
the effect of ACEIS to vasoconstriction induced by phenylephrine (PE), al -
adrenoceptor agcnist, The proportion of venous contraction was examined
with dorsal hand vein compliance technique. Quinapril (10 mg), an Iipophilic
ACEI, or Enalapril (10 mg), an hydrophilic ACEI, were administered in 6
healthy male volunteers twice, 22 and 3 houra before examinations, in a
cross over manner. Systolic blood pressura (SBP) was decreased after each
drug administration. ACEIS shifted the dose-response curve to right and
raised the median effective dose (ED50). The right-shift by quinapril was
greater than by enalapril. The maximum effect (Emax) was not changed.
SBP(mmHg) ED50(ug/ml) Emax (O/.)
Control 111.3+ 2.8 189.3 + 57,6 86.9 & 4.3
Enalapril 103.7 * 1,4* 266.8 k 55,8 87,5 h 5,1
Quinapril 104.1 + 2,3$ 461.1 + 101.8” 61.4 + 3.1
*p <0.01
These findings suggest ACEIS reduce not only presynaptic sympathetic
out flow but also postsynaptic w -adrenergic receptor sensitivity in human
vessel. It has been reportedthat Iipophilic ACEISsuppress tiesue angiotensin
II concentrations greater than hydrophilic ones. On based on our obsewa-
tions, tissue angiotensin II concentration may play a key role in postsynaptic
modulation of q -adrenergic receptor sensitivity.
